Abstract:Abstract Background Mental disorders in comorbidity with chronic skin diseases may worsen disease outcome and patients’ quality of life. We hypothesized the comorbidity of depression, anxiety syndromes, or symptoms as attributable to biological mechanisms that the combined diseases share. Methods We conducted a systematic review based on the Preferred Reporting Items for Systematic Review and Meta-Analysis statement searching into PubMed, PsycInfo, and Scopus databases. We examined the literature regarding the comorbidity of psoriasis (Ps), atopic dermatitis (AD), or hidradenitis suppurativa with depression and/or anxiety in adults ≥18 years and the hypothetical shared underlying biological mechanisms. Results Sixteen studies were analyzed, mostly regarding Ps and AD. Brain-derived neurotrophic factor/tropomyosin receptor kinase B signaling and nuclear factor kappa-light-chain-enhancer of activated B cells/p38 mitogen-activated protein kinase pathways arose as shared mechanisms in Ps animal models with depression- and/or anxiety-like behaviors. Activated microglia and neuroinflammatory responses emerged in AD depressive models. As to genetic studies, atopic-dermatitis patients with comorbid anxiety traits carried the short variant of serotonin transporter and a polymorphism of the human translocator protein gene. A GA genotype of catechol-O-methyltransferase gene was instead associated with Ps. Reduced natural killer cell activity, IL-4, serotonin serum levels, and increased plasma cortisol and IgE levels were hypothesized in comorbid depressive AD patients. In Ps patients with comorbid depression, high serum concentrations of IL-6 and IL-18, as well as IL-17A, were presumed to act as shared inflammatory mechanisms. Conclusions Further studies should investigate mental disorders and chronic skin diseases concurrently across patients’ life course and identify their temporal relation and biological correlates. Future research should also identify biological characteristics of individuals at high risk of the comorbid disorders and associated complications.

Gut–Brain–Skin Axis in Psoriasis: A Review

Gut–Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis

T cell-mediated skin-brain axis: Bridging the gap between psoriasis and psychiatric comorbidities

Gut microbiota and skin pathologies: Mechanism of the gut-skin axis in atopic dermatitis and psoriasis

The Brain–Skin Connection and the Pathogenesis of Psoriasis: A Review with a Focus on the Serotonergic System

"Gut-skin"axis: understanding psoriasis from the gut

Skin and Gut Microbiome in Psoriasis: Gaining Insight Into the Pathophysiology of It and Finding Novel Therapeutic Strategies

The mind–skin connection: A narrative review exploring the link between inflammatory skin diseases and psychological stress

Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions

The Mind Body Connection in Dermatologic Conditions: A Literature Review

Gut–Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions

The brain-skin axis in vitiligo

A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa

The Skin Microbiome and Its Role in Psoriasis: A Review

Effects on peripheral and central nervous system of key inflammatory intercellular signalling peptides and proteins in psoriasis

Cutaneous and Systemic Psoriasis: Classifications and Classification for the Distinction

Advances in the mechanism of action of short-chain fatty acids in psoriasis

Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review

Unveiling the Gut-skin Axis: How Gut Health Influences Dermatological Well-being

The role of short-chain fatty acids in inflammatory skin diseases

From gut to brain: understanding the role of microbiota in inflammatory bowel disease